BP
NUS icon

Ballentine Partners’s Nu Skin NUS Stock Holding History

Ballentine Partners’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,735
Closed -$158K – 1042
2025
Q1 		$158K Buy
21,735
+879
+4% +$6.39K ﹤0.01% 834
2024
Q4 		$144K Buy
20,856
+2,800
+16% +$19.3K ﹤0.01% 813
2024
Q3 		$133K Buy
+18,056
New +$169K ﹤0.01% 783

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ballentine Partners's NUS Position: Q2 2025 in Review

Ballentine Partners sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 21,735 shares — an estimated $158K sold.

Ballentine Partners first reported a position in NUS in Q3 2024 and held it in 3 quarters. The position peaked at $158K in Q1 2025. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

  • Ballentine Partners reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
  • Ballentine Partners sold 21,735 Nu Skin shares in Q2 2025, an estimated $158K.
  • Ballentine Partners first reported a position in Nu Skin in Q3 2024 and held it in 3 quarters.
  • Ballentine Partners's Nu Skin position peaked at $158K in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Ballentine Partners's 13F filing for Q2 2025, filed 15 Jul 2025.